Linked Life Data

15081626

Source:http://linkedlifedata.com/resource/pubmed/id/15081626

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-4-14
pubmed:abstractText
Understanding the factors that impede and promote adherence by people with schizophrenia to neuroleptic medication is important for treatment planning and relapse prevention. A total of 184 DSM-IV schizophrenia inpatients were examined with the Rating of Medication Influences (ROMI) scale within a context of inpatient vocational rehabilitation. Confirmatory factor analysis was used to evaluate the underlying dimensions of compliance behavior. The three-dimensional model of Weiden and his associates was confirmed by this study; specific factors included influence of others, medication affinity, and prevention. Additional analyses examined cognitive variables, symptoms, and course variables as predictors of individual factors. Verbal memory and cognitive flexibility were found to be associated with influence of others. Possible consequences for designing compliance enhancing therapeutic interventions are discussed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0165-1781
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
126
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
43-9
pubmed:dateRevised
2008-4-17
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Understanding adherence to neuroleptic treatment in schizophreniaí.
pubmed:affiliation
Department of Psychiatric Outpatient Treatment (Psychiatrische Universitätspoliklinik), University Hospital of Basel, Claragraben 95, CH-4005 Basel, Switzerland. rvauth@uhbs.ch
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't